RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Sunmax Biotechnology Co Debt 2024

Sunmax Biotechnology Co Debt

-685.68 TWD

Sunmax Biotechnology Co Dividend yield

2.91 %

Ticker

4728.TWO

ISIN

TW0004728001

In 2024, Sunmax Biotechnology Co's total debt was -685.68 TWD, a 30.3% change from the -526.21 TWD total debt recorded in the previous year.

Sunmax Biotechnology Co Aktienanalyse

What does Sunmax Biotechnology Co do?

Sunmax Biotechnology Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Sunmax Biotechnology Co's Debt Structure

Sunmax Biotechnology Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Sunmax Biotechnology Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Sunmax Biotechnology Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Sunmax Biotechnology Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Sunmax Biotechnology Co Stock

What is the debt of Sunmax Biotechnology Co this year?

Sunmax Biotechnology Co has a debt level of -685.68 TWD this year.

What was the debt of Sunmax Biotechnology Co compared to the previous year?

The debt of Sunmax Biotechnology Co has increased by 30.3% compared to the previous year increased.

What are the consequences of high debt for investors in Sunmax Biotechnology Co?

High debt can pose a risk for investors of Sunmax Biotechnology Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Sunmax Biotechnology Co?

Low debt means that Sunmax Biotechnology Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Sunmax Biotechnology Co affect the company?

An increase in debt of Sunmax Biotechnology Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Sunmax Biotechnology Co affect the company?

A reduction in debt of Sunmax Biotechnology Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Sunmax Biotechnology Co?

Some factors that can influence the debt of Sunmax Biotechnology Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Sunmax Biotechnology Co so important for investors?

The debts of Sunmax Biotechnology Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Sunmax Biotechnology Co take to change the debt?

To change the debt, Sunmax Biotechnology Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Sunmax Biotechnology Co pay?

Over the past 12 months, Sunmax Biotechnology Co paid a dividend of 9.5 TWD . This corresponds to a dividend yield of about 2.91 %. For the coming 12 months, Sunmax Biotechnology Co is expected to pay a dividend of 9.5 TWD.

What is the dividend yield of Sunmax Biotechnology Co?

The current dividend yield of Sunmax Biotechnology Co is 2.91 %.

When does Sunmax Biotechnology Co pay dividends?

Sunmax Biotechnology Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sunmax Biotechnology Co?

Sunmax Biotechnology Co paid dividends every year for the past 2 years.

What is the dividend of Sunmax Biotechnology Co?

For the upcoming 12 months, dividends amounting to 9.5 TWD are expected. This corresponds to a dividend yield of 2.91 %.

In which sector is Sunmax Biotechnology Co located?

Sunmax Biotechnology Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sunmax Biotechnology Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sunmax Biotechnology Co from 8/8/2023 amounting to 9.5 TWD, you needed to have the stock in your portfolio before the ex-date on 7/18/2023.

When did Sunmax Biotechnology Co pay the last dividend?

The last dividend was paid out on 8/8/2023.

What was the dividend of Sunmax Biotechnology Co in the year 2023?

In the year 2023, Sunmax Biotechnology Co distributed 4.4 TWD as dividends.

In which currency does Sunmax Biotechnology Co pay out the dividend?

The dividends of Sunmax Biotechnology Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sunmax Biotechnology Co

Our stock analysis for Sunmax Biotechnology Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sunmax Biotechnology Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.